|
HNRNPC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.192200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.459400E-01 |
| Normal-vs-Stage2 |
4.935000E-01 |
| Normal-vs-Stage3 |
4.651600E-02 |
| Normal-vs-Stage4 |
3.812600E-04 |
| Stage1-vs-Stage2 |
7.784600E-01 |
| Stage1-vs-Stage3 |
1.064220E-01 |
| Stage1-vs-Stage4 |
5.006500E-04 |
| Stage2-vs-Stage3 |
2.662000E-01 |
| Stage2-vs-Stage4 |
5.356000E-03 |
| Stage3-vs-Stage4 |
1.678140E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.819970E-01 |
| Normal-vs-AfricanAmerican |
2.938200E-01 |
| Normal-vs-Asian |
1.239240E-01 |
| Caucasian-vs-AfricanAmerican |
6.553000E-01 |
| Caucasian-vs-Asian |
4.261600E-01 |
| AfricanAmerican-vs-Asian |
2.913400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.382800E-01 |
| Normal-vs-Female |
4.358000E-02 |
| Male-vs-Female |
1.291380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.960200E-02 |
| Normal-vs-Extreme_Weight |
3.821200E-01 |
| Normal-vs-Obese |
8.704300E-02 |
| Normal-vs-Extreme_Obese |
9.345000E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.004600E-01 |
| Normal_Weight-vs-Obese |
9.192000E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.645600E-01 |
| Extreme_Weight-vs-Obese |
2.884800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.372600E-01 |
| Obese-vs-Extreme_Obese |
2.471600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.284010E-02 |
| Normal-vs-Age(41-60Yrs) |
8.603800E-02 |
| Normal-vs-Age(61-80Yrs) |
5.803600E-01 |
| Normal-vs-Age(81-100Yrs) |
8.447000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.592640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.728240E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.728200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.695800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.353400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.612600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.538960E-01 |
| Normal-VS-Type2 PRCC |
7.732400E-01 |
| Normal-VS-KIRP CIMP |
8.49529999999987E-05 |
| Normal-VS-Unclassified PRCC |
9.813800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.456800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.024600E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
1.301800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.576380E-04 |
| Type2 PRCC-VS-Unclassified PRCC |
7.465400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.60979999999489E-05 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.884200E-01 |
| Normal-vs-N1 |
5.91899999999868E-05 |
| Normal-vs-N2 |
1.774590E-01 |
| N0-vs-N1 |
1.63729000000057E-05 |
| N0-vs-N2 |
2.012000E-01 |
| N1-vs-N2 |
3.693800E-01 |
|
|
